Sex and schizophrenia: a review of gender differences

Psychosis

Volumn 6, Issue 1, 2014, Pages 61-69

  Falkenburg, Jara ^a,b   Tracy, Derek K ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b OXLEAS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

gender; schizophrenia; sex

Indexed keywords

EID: 84897642759     PISSN: 17522439     EISSN: 17522447     Source Type: Journal    
DOI: 10.1080/17522439.2012.733405     Document Type: Article

References (58)

1. Abel, K.M., Drake, R., & Goldstein, J.M. (2010). Sex differences in schizophrenia. International Review of Psychiatry, 22(5), 417-428.
2. Aleman, A., Kahn, R.S., & Selten, J.-P. (2003). Sex differences in the risk of schizophrenia: Evidence from meta-analysis. Archives of General Psychiatry, 60(6), 565-571.
3. an der Heiden, W., & Häfner, H. (2000). The epidemiology of onset and course of schizophrenia. European Archives of Psychiatry and Clinical Neurosciences, 250, 292-303.
4. Bentall, R., Wickham, S., Shevlin, M., & Varese, F. (2012). Do specific early-life adversities lead to specific symptoms of psychosis? A study from the 2007 the Adult Psychiatric Morbidity Survey. Schizophrenia Bulletin, 38(4), 734-740.
5. Bora, E., Fornito, A., Yücel, M., & Pantelis, C. (2012). The effects of gender on grey matter abnormalities in major psychoses: A comparative voxelwise meta-analysis of schizophrenia and bipolar disorder. Psychological Medicine, 42(2), 295-307.
6. Brabban, A., Tai, S., & Turkington, D. (2009). Predictors of outcome in Brief Cognitive Behavior Therapy for schizophrenia. Schizophrenia Bulletin, 35(5), 859-864.
7. Brady, N., & McCain, G.C. (2004). Living with schizophrenia: A family perspective. Online Journal of Issues in Nursing, 10(1), 7-17.
8. Brown, A.S., & Susser, E.S. (2008). Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophrenia Bulletin, 34(6), 1054-1063.
9. Bundy, H., Stahl, D., & MacCabe, J.H. (2011). A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives. Acta Psychiatrica Scandinavica, 123(2), 98-106.
10. Bushe, C., Yeomans, D., Floyd, T., & Smith, S.M. (2008). Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics. Journal of Psychopharmacology, 22(2 SUPPL.), 56-62.
11. Chang, W.C., Tang, J.Y.M., Hui, C.L.M., Chiu, C.P.Y., Lam, M.M.L., Wong, G.H.Y., Chen, E.Y.H. (2011). Gender differences in patients presenting with first-episode psychosis in Hong Kong: A three-year follow up study. Australian and New Zealand Journal of Psychiatry, 45(3), 199-205.
12. Chua, W.L., de Santiago, A.I., Kulkarni, J., & Mortimer, A. (2010). Estrogen for schizophrenia. Cochrane Database of Systematic Review, (4).
13. Doucet, S., Jones, I., Letourneau, N., Dennis, C.-L., & Blackmore, E. (2011). Interventions for the prevention and treatment of postpartum psychosis: A systematic review. Archives of Women's Mental Health, 14(2), 89-98.
14. Fisher, H.L., Craig, T.K., Fearon, P., Morgan, K., Dazzan, P., Lappin, J., & Morgan, C. (2011). Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophrenia Bulletin, 112, 330-350.
15. Fortinguerra, F., Clavenna, A., & Bonati, M. (2009). Psychotropic drug use during breastfeeding: A review of the evidence. Pediatrics, 124(4), e547-e556.
16. Goldstein, J.M., & Lewine, R.R.J. (2000). Overview of sex differences in schizophrenia. In D.J. Castle, J. McGrath, & J. Kulkarni (Eds.), Women and schizophrenia (pp. 111-143). Cambridge: Cambridge University Press.
17. Good, K.P., Kopala, L.C., Martzke, J.S., Fluker, M., Seeman, M.V., Parish, B., Whitehorne, L. (1999). Hormone replacement therapy in postmenopausal women with schizophrenia: Preliminary findings. Schizophrenia Research, 12 (3), 131.
18. Grubaugh, A.L., Zinzow, H.M., Paul, L., Egede, L.E., & Frueh, B.C. (2011). Trauma exposure and posttraumatic stress disorder in adults with severe mental illness: A critical review. Clinical Psychology Review, 31(6), 883-899.
19. Häfner, H. (2003). Gender differences in schizophrenia. Psychoneuroendocrinology, 28(1002), 17-54.
20. Kring, A.M., & Moran, E.K. (2008). Emotional response deficits in schizophrenia: Insights from affective science. Schizophrenia Bulletin, 34(5), 819-834.
21. Kulkarni, J., de Castella, A., Headey, B., Marston, N., Sinclair, K., Lee, S., Burger, H. (2011). Estrogens and men with schizophrenia: Is there a case for adjunctive therapy? Schizophrenia Research, 125(2-3), 278-283.
22. Landolt, K., Rössler, W., Burns, T., Ajdacic-Gross, V., Galderisi, S., Libiger, J., Fleischhacker, W.W. (2012). Unmet needs in patients with first-episode schizophrenia: A longitudinal perspective. Psychological Medicine, 42, 1461-1473.
23. Leung, A., & Chue, P. (2000). Sex differences in schizophrenia: A review of the literature. Acta Psychiatrica Scandinavica, 101(401), 3-38.
24. Martínez-Ortega, J.M., Carretero, M.D., Gutiérrez-Rojas, L., Díaz-Atienza, F., Jurado, D., & Gurpegui, M. (2011). Winter birth excess in schizophrenia and in non-schizophrenic psychosis: Sex and birth-cohort differences. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(7), 1780-1784.
25. Marwaha, S., & Johnson, S. (2004). Schizophrenia and employment - a review. Soc Psychiatry Psychiatr Epidemiol, 39, 337-349.
26. McGrath, J., Saha, S., Chant, D., & Welham, J. (2008). Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews, 30(1), 67-76.
27. Moldin, S.O. (2000). Gender and schizophrenia. In: E. Frank (Ed.), Gender and its effects on psychopathology. Washington, DC: American Psychiatric Press.
28. Morgan, C., & Hutchinson, G. (2010). The sociodevelopmental origins of psychosis. In: C. Morgan & D. Bhugra (Eds.), Principles of social psychiatry. (2nd ed.). (pp. 193-213). Chichester: John Wiley.
29. Morgan, V.A., Castle, D.J., & Jablensky, A.V. (2008). Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders. Australian and New Zealand Journal of Psychiatry, 42(1), 74-82.
30. Morken, G., Widen, J., & Grawe, R. (2008). Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia. BMC Psychiatry, 8 (1), 32.
31. Olsen, L., Hansen, T., Jakobsen, K., Djurovic, S., Melle, I., Agartz, I., Werge, T. (2008). The estrogen hypothesis of Schizophrenia implicates glucose metabolism: Association study in three independent samples. BMC Medical Genetics, 9 (1), 39.
32. Perala, J., Suvisaari, J., Saarni, S.I., Kuoppasalmi, K., Isometsa, E., Pirkola, S., & Lonnqvist, J. (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry, 64(1), 19-28.
33. Premkumar, P., Peters, E.R., Fannon, D., Anilkumar, A.P., Kuipers, E., & Kumari, V. (2011). Coping styles predict responsiveness to cognitive behaviour therapy in psychosis. Psychiatry Research, 187(3), 354-362.
34. Pruessner, M., Boekestyn, L., Béchard-Evans, L., Abadi, S., Vracotas, N., Joober, R., & Malla, A.K. (2008). Sex differences in the cortisol response to awakening in recent onset psychosis. Psychoneuroendocrinology, 33(8), 1151-1154.
35. Rapoport, J.L., Addington, A.M., Frangou, S., & Psych, M.R.C. (2005). The neurodevelopmental model of schizophrenia: Update 2005. Mol Psychiatry, 10(5), 434-449.
36. Read, J., Bentall, R.P., & Fosse, R. (2009). Time to abandon the bio-bio-bio model of psychosis: Exploring the epigenetic and psychological mechanisms by which adverse life events lead to psychotic symptoms. Epidemiol Psichiatr Soc, 18(4), 299-310.
37. Rector, N.A., & Seeman, M.V. (1992). Auditory hallucinations in women and men. Schizophrenia Research, 7(3), 233-236.
38. Riecher-Rossler, A., Pfluger, M., & Borgwardt, S. (2010). Schizophrenia in women. In: D. Kohen (Ed.), Oxford textbook of women and mental health (pp. 102-111). Oxford: Oxford University Press.
39. Russell, J.M., & Mackell, J.A. (2001). Bodyweight gain associated with atypical antipsychotics: Epidemiology and therapeutic implications. CNS Drugs, 15(7), 537-551.
40. Saha, S., Chant, D., Welham, J., & McGrath, J. (2005). A systematic review of the prevalence of schizophrenia. PLoS Med, 2(5), e141.
41. Seeman, M.V. (2004). Gender differences in the prescribing of antipsychotic drugs. American Journal of Psychiatry, 161, 1324-1333.
42. Seeman, M.V. (2008). Gender. In K.T. Mueser & D.V. Jeste (Eds.), Clinical handbook of schizophrenia (pp. 575-580). New York, NY: The Guilford Press.
43. Seeman, M.V. (2009). Secondary effects of antipsychotics: Women at greater risk than men. Schizophrenia Bulletin, 35(5), 937-948.
44. Seeman, M.V. (2012). Menstrual exacerbation of schizophrenia symptoms. Acta Psychiatrica Scandinavica, 59, 347-398.
45. Sideli, L., Mule, A., La Barbera, D., & Murray, R.M. (2012). Do child abuse and maltreatment increase risk of schizophrenia? Psychiatry Investig, 9, 87-89.
46. Smith, S. (2010). Gender differences in antipsychotic prescribing. International Review of Psychiatry, 22(5), 472-484.
47. Sørensen, H.J., Mortensen, E.L., Reinisch, J.M., & Mednick, S.A. (2009). Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophrenia Bulletin, 35(3), 631-637.
48. Steen, N.E., Lorentzen, S., Barrett, E.A., Lagerberg, T.V., Hope, S., Larsson, S., & Andreassen, O.A. (2011). Sex-specific cortisol levels in bipolar disorder and schizophrenia during mental challenge: Relationship to clinical characteristics and medication. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(4), 1100-1107.
49. Thornicroft, G., Brohan, E., Rose, D., Sarorius, N., Leese, M., & INDIGO Study Group. (2009). Global pattern of experienced and anticipated discrimination against people with schizophrenia: A cross-sectional survey. Lancet, 373, 408-415.
50. Torniainen, M., Suvisaari, J., Partonen, T., Castaneda, A.E., Kuha, A., Perälä, J., & Tuulio-Henriksson, A. (2011). Sex differences in cognition among persons with schizophrenia and healthy first-degree relatives. Psychiatry Research, 188(1), 7-12.
51. Tunde-Ayinmode, M., Singh, A.K., & Marsden, K. (2002). Improved functioning in a woman with schizophrenia on exclusive therapy with oestrogen pills. Australasian Psychiatry, 10(4), 403-404.
52. Üçok, A., Gorwood, P., & Karadayi, G. (2011). Employment and its relationship with functionality and quality of life in schizophrenia: EGOFORS Study. European Psychiatry, 27, 422-425.
53. Usall, J., Araya, S., Ochoa, S., Busquets, E., Gost, A., Márquez, M., & the Assessment Research Group in, S. (2001). Gender differences in a sample of schizophrenic outpatients. Comprehensive Psychiatry, 42 (4), 301-305.
54. Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., Bentall, R.P. (2012). Childhood adversities increase the risk of psychosis: A meta-analysis of patient-control, prospective and cross-sectional Cohort studies. Schizophrenia Bulletin, 38(4), 661-671.
55. Walton, E., Turner, J., Gollub, R.L., Manoach, D.S., Yendiki, A., Ho, B.-C., Ehrlich, S. (2012). Cumulative genetic risk and prefrontal activity in patients with schizophrenia. Schizophrenia Bulletin, 38(1).
56. Weinberger, D.R., & Levitt, P. (2011). Neurodevelopmental origins of schizophrenia. In: D. R. Weinberger & P. J. Harrison (Eds.), Schizophrenia. (3rd ed.). (pp. 393-412). Oxford: Wiley-Blackwell.
57. World Health Organisation. (2010). Gender disparities in mental health. Geneva: World Health Organisation.
58. Xiang, Y.-T., Wang, C.-Y., Weng, Y.-Z., Bo, Q.-J., Chiu, H.F.K., Zhao, J.-P., Ungvari, G.S. (2010). Sex differences in patients with schizophrenia: A prospective, multi-center study. Psychiatry Research, 177(3), 294-298.